12,372 trials
Bowel Preparation
Primary: Percentage of Participants Classified as Successes (Excellent and Good Ratings) According to the Aronchick Scale As Assessed by a Blinded Gastroenterologist — 84.2; 74.4…
Bowel Preparation
Primary: Percentage of Participants Classified as Successes (Excellent and Good Ratings) According to the Aronchick Scale As Assessed by a Blinded Gastroenterologist — 83.0; 79.7…
Schizophrenia
Primary: Incidence of Adverse Events — 97.4 percentage of patients
Peripheral Vascular Disease
Primary: Major Adverse Event (MAE) Rate — 6.1 percentage of participants
Seasonal Allergic Rhinitis
Primary: Change From Baseline in 12 Hour Reflective Total Nasal Symptom Score (rTNSS) — -5.5; -4.8; -4.9; -3.4 units on a scale
Rhinoconjunctivitis · Rhinitis · Conjunctivitis
Primary: Participant Total Combined Symptom (TCS) Score Over the Entire Grass Pollen Season (GPS) — 5.08; 6.39 Units on a Scale — p==0.005
Seasonal Allergic Rhinitis
Primary: Change From Baseline in 12 Hour Reflective Total Nasal Symptom Score (rTNSS) — -5.5; -4.5; -4.6; -3.0 units on a scale
Rhinoconjunctivitis · Rhinitis · Conjunctivitis
Primary: Participant Total Combined Symptom (TCS) Score Over the Entire Grass Pollen Season (GPS) — 4.62; 6.25 Units on a Scale — p==0.001
Brain and Central Nervous System Tumors · Chronic Myeloproliferative Disorders · Leukemia
Primary: Pain Intensity — 5.60; 6.44; 5.11; 5.98 units on a scale
Low Back Pain
Primary: Change in FFbH-R Between Screening and Week 15 — 8.8; 4.1 units on a scale — p=0.0426
Breast Cancer
Primary: Best Overall Response Rate (BORR) (Calliper) — 70.4; 50.5 Percentage of Participants
Obesity · Type 2 Diabetes
Primary: Percent Weight Loss From Baseline to Week 56 — 1.24; 7.81; 9.84 percent weight loss — p=<0.0001
Obesity
Primary: Percent Weight Loss From Baseline to Week 56 — 1.55; 5.10; 10.92 percent weight loss — p=<0.0001
Colorectal Cancer
Primary: Disease-free Survival in Stage III Cancer Patients - Time to Event — NA; NA; NA months — p=0.2024
Stomach Cancer
Primary: Relapse-free Survival — 50.0; 60.2 percentage of participants